Behavioral effects of MDMA ('ecstasy') on adult zebrafish

  • Adam Stewart
  • , Russell Riehl
  • , Keith Wong
  • , Jeremy Green
  • , Jessica Cosgrove
  • , Karoly Vollmer
  • , Evan Kyzar
  • , Peter Hart
  • , Alexander Allain
  • , Jonathan Cachat
  • , Siddharth Gaikwad
  • , Molly Hook
  • , Kate Rhymes
  • , Alan Newman
  • , Eli Utterback
  • , Katie Chang
  • , Allan V. Kalueff

Research output: Contribution to journalArticlepeer-review

61 Citations (Scopus)

Abstract

3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy') is a potent psychedelic drug inducing euphoria and hypersociability in humans, as well as hyperactivity and anxiety in rodents. Adult zebrafish (Danio rerio) have become a widely used species in neurobehavioral research. Here, we explore the effects of a wide range (0.25-120 mg/l) of acute MDMA doses on zebrafish behavior in the novel tank test. Although MDMA was inactive at lower doses (0.25-10 mg/l), higher doses reduced bottom swimming and immobility (40-120 mg/l) and impaired intrasession habituation (10-120 mg/l). MDMA also elevated brain c-fos expression, collectively confirming the usage of zebrafish models for screening of hallucinogenic compounds.

Original languageEnglish
Pages (from-to)275-280
Number of pages6
JournalBehavioural Pharmacology
Volume22
Issue number3
DOIs
Publication statusPublished - Jun 2011
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 3,4-methylenedioxymethamphetamine
  • anxiety
  • locomotion
  • novelty-based paradigms
  • psychedelic hallucinogenic drugs
  • zebrafish

Fingerprint

Dive into the research topics of 'Behavioral effects of MDMA ('ecstasy') on adult zebrafish'. Together they form a unique fingerprint.

Cite this